Abstract |
A randomized, prospective study compared a long-acting, second-generation cephalosporin, cefonicid ( Monocid), with a short-acting, second-generation cephalosporin, cefoxitin ( Mefoxin), for cesarean section prophylaxis. One hundred thirty-nine patients were enrolled, with 81 receiving a 1-g intravenous dose of cefonicid after cord clamping and 58 receiving a 2-g dose of intravenous cefoxitin after cord clamping and at 6, 12 and 18 hours postpartum. In those patients receiving cefonicid prophylaxis, endometritis incidence was 17.3% (14 of 81). This finding was not statistically significant (P less than .397) when compared to the 12.1% incidence of endometritis (7 of 58) with cefoxitin. In addition, the febrile morbidity incidence for cefonicid prophylaxis was 23.5% (19 of 81) as compared to 15.5% (9 of 58) for cefoxitin (P less than .25). Because the two drugs appear to be equally efficacious, cefonicid may be the better choice because of its markedly lower cost.
|
Authors | R A Hartert Jr, G Benrubi, R J Thompson, R C Nuss |
Journal | The Journal of reproductive medicine
(J Reprod Med)
Vol. 32
Issue 12
Pg. 907-10
(Dec 1987)
ISSN: 0024-7758 [Print] United States |
PMID | 3430499
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Cefamandole
- Cefonicid
- Cefoxitin
|
Topics |
- Adult
- Age Factors
- Cefamandole
(analogs & derivatives, therapeutic use)
- Cefonicid
- Cefoxitin
(therapeutic use)
- Cesarean Section
(adverse effects)
- Endometritis
(economics, prevention & control)
- Female
- Humans
- Pregnancy
- Prospective Studies
- Random Allocation
- Risk Factors
- Socioeconomic Factors
|